Safety, Tolerability, Extended Early Bactericidal Activity and PK of Higher Doses Rifampicin in Adults With Pulmonary TB

NCT01392911 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

128

Enrollment

OTHER

Sponsor class

Conditions

Pulmonary Tuberculosis (TB)

Interventions

DRUG: Rifampicin

Sponsor

Radboud University Medical Center

Collaborators

[object Object]
[object Object]
[object Object]